(Q67126141)
Statements
Pilot Single Arm, Single Center, Open Label Trial of Pembrolizumab in Patients With Intermediate and High Risk Smoldering Multiple Myeloma (English)
0 references
20 July 2016
0 references
30 July 2020
0 references
13
0 references
18 year
0 references